Lisa Karageozian

发表

Safety and Efficacy of Intravitreal Risuteganib for Non-Exudative AMD: A Multicenter, Phase 2a, Randomized, Clinical Trial.

P. Kaiser, B. Kuppermann, H. Quiroz-Mercado, 2021, Ophthalmic surgery, lasers & imaging retina.

Color Vision and Microperimetry Changes in Nonexudative Age-Related Macular Degeneration After Risuteganib Treatment: Exploratory Endpoints in a Multicenter Phase 2a Double-Masked, Randomized, Sham-Controlled, Crossover Clinical Trial.

P. Kaiser, B. Kuppermann, H. Quiroz-Mercado, 2022, Ophthalmic surgery, lasers & imaging retina.